Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy.
Gaiad, T P; Silva, M B; Silva, G C A; Caromano, F A; Miglino, M A; Ambrósio, C E.
Res Vet Sci
; 91(2): 188-93, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21315399
Physical exertion exacerbates decline in the musculature of an animal model of Duchenne muscular dystrophy.
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.
PGC-1α gene transfer improves muscle function in dystrophic muscle following prolonged disease progress.
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy?
Innervation of dystrophic muscle after muscle stem cell therapy.
Exon Skipping Therapy.
Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs.
Monitoring disease activity noninvasively in the <i>mdx</i> model of Duchenne muscular dystrophy.